Model Number 104911 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Aortic Regurgitation (1716); Right Ventricular Dysfunction (2054)
|
Event Date 06/04/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Event date estimated.Date of imaging used.No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
|
|
Event Description
|
(b)(6) 2020 echo revealed mild continuous aortic regurgitation.Right ventricular cavity size was mildly dilated with mildly decreased right ventricular systolic function.La moderately dilated.There was mild dilatation of the ascending aorta.
|
|
Manufacturer Narrative
|
Manufacturer's investigation conclusion: a direct correlation between (b)(6) and the reported right heart failure and regurgitation could not be conclusively determined through this evaluation.Multiple requests for additional information regarding this event were submitted to the account; no response has been received at this time.The heartmate ii left ventricular assist system (lvas) instructions for use (ifu) lists right heart failure as a possible adverse event associated with the use of hmii therapy.This document also warns that moderate to severe aortic insufficiency must be corrected at time of device implant.The patent remains ongoing on (b)(6).Heartmate ii (hmii) left ventricular assist system (lvas) instructions for use (ifu) is currently available.Section 1 of this document lists right heart failure as a possible adverse event associated with the use of hmii therapy.Section 5 "surgical procedures" warns that moderate to severe aortic insufficiency must be corrected at time of device implant.Section 6 ¿patient care and management¿ describes that right heart failure can occur post-implant and provides strategies for treating patients who experience right heart failure.No further information was provided.The manufacturer is closing the file on this event.
|
|
Search Alerts/Recalls
|